ASH Conference Coverage
Featured Articles
(Reuters) Dec 9, 2019 - Bluebird bio Inc and Bristol-Myers Squibb Co on Monday reported encouraging initial data from an ongoing early-stage study testing their experimental therapy for multiple myeloma in patients who did not respond to prior treatments. The lowest dose of the therapy, bb21217, had a median duration of response of...
Read Article
(ASH) Dec 10, 2019 - The immunotherapy drug blinatumomab significantly improved survival in children with relapsed B-acute lymphoblastic leukemia (B-ALL) compared with standard chemotherapy in a study presented today during the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando. Researchers say the...
Read Article
Latest Articles
December 12, 2019
December 10, 2019
December 10, 2019
December 10, 2019
December 10, 2019
December 10, 2019
December 10, 2019
December 10, 2019
View More
News Commentary
There is no ASH Conference Coverage commentary.

OBR Blog
As the ASH Annual Meeting concludes, the late-breaking abstracts are always of great interest. We take a brief look at... Read more
December 04, 2018
As the 2018 American Society of Hematology (ASH) Annual Meeting continues, we focus on two studies that have the... Read more
December 04, 2018

OBR Tweets

Apr 03
Howard S. Hochster, MD: Interesting news on the KEYNOTE-177 first line MSI-H colon cancer trial. This is a 1:1 ran… https://t.co/Nx3Qp46jxN

Apr 01
Dean Gesme, MD: The reported low false positive rate in this large validation data set and high diagnostic acumen f… https://t.co/rGmVtpQ5lu

Mar 31
William McGivney, PhD: Kudos to CIGNA and to Humana and all those who helped drive the decisions of these two large… https://t.co/HF8BZCWGF7

Mar 30
H. Jack West, MD: This provides another option that is pretty much a lateral move compared to atezolizumab with che… https://t.co/hnkRD0AfXw

Mar 26
Howard S. Hochster, MD: There is no question that SARS-CoV-2 will prove to be a major challenge to all health care… https://t.co/EyJijktM68

Mar 25
OBR speaks to providers at community oncology practices like Florida Cancer Specialists & Research Institute (FCS)… https://t.co/3qyne3w9gE

Mar 25
Dr. David Penson of Vanderbilt University Medical Center @VUmedicine delves into Financial toxicity and its negativ… https://t.co/o2IUnKvcff

Mar 25
Dr. Azra Raza @AzraRazaMD, an Oncologist at @Columbia, speaks to us about her recently published book @thefirstcell… https://t.co/x1HmTvHta7

Mar 25
H. Jack West, MD: An excellent piece that highlights what the history of cancer research should be teaching the wor… https://t.co/QAEpZJP8ov

Mar 24
Preparing your Oncology Clinic for COVID-19 Infections - Webinar Archive Now Available https://t.co/CV2a4q4DUl ft.… https://t.co/KvibaK0WdL